Browse by Phase
Phase 1 Clinical Trials
Phase 1 trials test a new drug or treatment in a small group (20–80 people) for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects.
Total Trials
551
Recruiting Now
551
Top Conditions in Phase 1
NCT06465316 Phase 1
Recruiting
Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Re...
Condition
Recurrent Multiple Myeloma
Enrollment
26 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06519552 Phase 1
Recruiting
A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of JW...
Condition
Mucopolysaccharidosis Type I
Enrollment
6 pts
Location
China
Sponsor
West China Hospital
NCT06920238 Phase 1
Recruiting
Use of a Generative AI (Gen-AI) Chatbot for Anxiety and Depression Among Persons...
Condition
Cannabis Use Disorder
Enrollment
15 pts
Location
United States
Sponsor
Trustees of Dartmouth College
NCT06868732 Phase 1
Recruiting
Evaluation of JSKN016 Combination Therapy in Subjects With NSCLC
Condition
Advanced Non-small Cell Lung Cancer
Enrollment
288 pts
Location
China
Sponsor
Jiangsu Alphamab Biopharmaceut
NCT05686798 Phase 1
Recruiting
Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astroc...
Condition
Malignant Glioma of Brain
Enrollment
18 pts
Location
United States
Sponsor
Henry Ford Health System
NCT05581004 Phase 1
Recruiting
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a...
Condition
Locally Advanced or Metastatic Solid Tumors
Enrollment
450 pts
Location
United States, Australia, Belgium
Sponsor
Genentech, Inc.
NCT06586255 Phase 1
Recruiting
Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder ...
Condition
Urothelial Carcinoma Bladder
Enrollment
10 pts
Location
United States
Sponsor
Abramson Cancer Center at Penn
NCT04318678 Phase 1
Recruiting
CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
Condition
AML/MDS
Enrollment
108 pts
Location
United States
Sponsor
St. Jude Children's Research H
NCT07118085 Phase 1
Recruiting
A Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalat...
Condition
Healthy Postmenopausal Women
Enrollment
56 pts
Location
China
Sponsor
ImmuneOnco Biopharmaceuticals
NCT06867393 Phase 1
Recruiting
Safety, Tolerability, and Pharmacokinetics of HL-003 in Healthy Subjects
Condition
Healthy Subjects
Enrollment
52 pts
Location
China
Sponsor
Shanghai Kechow Pharma, Inc.
NCT07141706 Phase 1
Recruiting
A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors
Condition
Advanced/Metastatic Solid Tumors
Enrollment
233 pts
Location
United States, Australia
Sponsor
DualityBio Inc.
NCT07239947 Phase 1
Recruiting
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderat...
Condition
Atopic Dermatitis
Enrollment
63 pts
Location
China
Sponsor
Bambusa Therapeutics
NCT06938243 Phase 1
Recruiting
Wether VNS in Early Stage (3 Months) is Safe and More Beneficial for Post-stroke...
Condition
Stroke
Enrollment
100 pts
Location
China
Sponsor
Qilu Hospital of Shandong Univ
NCT06287515 Phase 1
Recruiting
Hypophysectomy by Stereotactic Radiosurgery for Cancer-Related Pain
Condition
Hypophysectomy
Enrollment
40 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06026774 Phase 1
Recruiting
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With...
Condition
Digestive System Neoplasms
Enrollment
20 pts
Location
China
Sponsor
Sir Run Run Shaw Hospital
NCT06909474 Phase 1
Recruiting
Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hema...
Condition
T-ALL/Lymphoma
Enrollment
15 pts
Location
China
Sponsor
Chongqing Precision Biotech Co
NCT07102342 Phase 1
Recruiting
This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibilit...
Condition
Parkinson Disease
Enrollment
5 pts
Location
United States
Sponsor
iRegene Therapeutics Co., Ltd.
NCT06173518 Phase 1
Recruiting
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed ...
Condition
Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia
Enrollment
30 pts
Location
United States, Spain, United Kingdom
Sponsor
Autolus Limited
NCT07138196 Phase 1
Recruiting
A Study to Evaluate Adrixetinib (Q702) in Adults With Active Chronic Graft-Versu...
Condition
Chronic Graft-Versus-Host Disease
Enrollment
18 pts
Location
Spain
Sponsor
Qurient Co., Ltd.
NCT07021066 Phase 1
Recruiting
Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in ...
Condition
Gastric Adenocarcinoma
Enrollment
120 pts
Location
United States
Sponsor
SystImmune Inc.
NCT07358546 Phase 1
Recruiting
A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
Condition
Non-alcoholic Fatty Liver Disease
Enrollment
32 pts
Location
United States
Sponsor
GlaxoSmithKline
NCT04953910 Phase 1
Recruiting
Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazur...
Condition
Acute Myeloid Leukemia
Enrollment
27 pts
Location
United States, Armenia, Bulgaria
Sponsor
Taiho Oncology, Inc.
NCT06714513 Phase 1
Recruiting
ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74
Condition
Tuberculosis, Pulmonary
Enrollment
144 pts
Location
South Korea
Sponsor
Quratis Inc.
NCT07329894 Phase 1
Recruiting
Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoa...
Condition
Gastrointestinal Cancer
Enrollment
18 pts
Location
China
Sponsor
Beijing GoBroad Hospital
NCT06772766 Phase 1
Recruiting
A Multiple Ascending Dose Study of 9MW3011 in Patients With Non-transfusion-depe...
Condition
Beta-Thalassemia
Enrollment
40 pts
Location
China
Sponsor
Mabwell (Shanghai) Bioscience